Ingredient

Momelotinib Hydrochloride Hydrate

Momelotinib hydrochloride hydrate is an active ingredient used in the treatment of hematological malignancies.

All medicines
3
Single ingredient
3
Prescription medication
3

MFDS ingredient code M284885

What does it do?

Momelotinib hydrochloride hydrate is an active ingredient used in the treatment of hematological malignancies, particularly prescribed for patients with specific blood cancers such as myelofibrosis. This ingredient is included in medications to inhibit the growth and proliferation of cancer cells.

Momelotinib hydrochloride hydrate blocks the activity of specific enzymes within cancer cells, disrupting the signaling that allows cancer cells to proliferate. This helps to suppress the growth of cancer cells and slows the progression of the disease.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Momelotinib hydrochloride hydrate is characterized by targeting specific enzymes, reducing side effects, and enhancing therapeutic efficacy compared to other chemotherapy agents. Additionally, it has a mechanism of action specialized for the treatment of hematological malignancies, distinguishing it from other antineoplastic agents.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.